Role of radiotherapy in the management of node-positive prostate cancer

Node-positive prostate cancer patients represent a small proportion of all prostate cancers for whom limited prospective information is available. Most retrospective or cohort data strongly suggest however that radiotherapy combined with androgen-depriving therapies is the preferable treatment in th...

Full description

Saved in:
Bibliographic Details
Published in:Cancer radiothérapie 2016-10, Vol.20 (6-7), p.442-444
Main Authors: Supiot, S, Doré, M, Rio, E, Cellier, P, Mesguez-Nebout, N, Goineau, A
Format: Article
Language:fre
Subjects:
Androgen Antagonists - therapeutic use
Humans
Lymphatic Metastasis
Male
Prostatic Neoplasms - drug therapy
Prostatic Neoplasms - pathology
Prostatic Neoplasms - radiotherapy
Radiotherapy, Adjuvant
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Node-positive prostate cancer patients represent a small proportion of all prostate cancers for whom limited prospective information is available. Most retrospective or cohort data strongly suggest however that radiotherapy combined with androgen-depriving therapies is the preferable treatment in this setting. Only randomized clinical trials would be able to better define both radiotherapy (dose? volume? fractionation?) and androgen-depriving therapies (duration? role of novel androgen-depriving therapy?) modalities.
ISSN:1769-6658
DOI:10.1016/j.canrad.2016.06.002